Vanguard Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2M | Buy |
|
|||||
|
2025
Q1 | $12.2M | Sell |
|
|||||
|
2024
Q4 | $15.4M | Buy |
|
|||||
|
2024
Q3 | $16.6M | Buy |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | $17M | Sell |
|
|||||
|
2023
Q4 | $11M | Buy |
|
|||||
|
2023
Q3 | $16.8M | Buy |
|
|||||
|
2023
Q2 | $1.05M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Buy |
|
|||||
|
2022
Q4 | $3.52M | Buy |
|
|||||
|
2022
Q3 | $2.07M | Hold |
|
|||||
|
2022
Q2 | $3.98M | Buy |
|
|||||
|
2022
Q1 | $6.6M | Buy |
|
|||||
|
2021
Q4 | $10.3M | Buy |
|
|||||
|
2021
Q3 | $15M | Buy |
|
|||||
|
2021
Q2 | $13.3M | Buy |
|
|||||
|
2021
Q1 | $9.34M | Sell |
|
|||||
|
2020
Q4 | $12.3M | Buy |
|
|||||
|
2020
Q3 | $1.68M | Buy |
|